Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
CA Cancer J Clin. 2022 Sep;72(5):437-453. doi: 10.3322/caac.21730. Epub 2022 May 18.
Approximately one-half of individuals with cancer face personal economic burdens associated with the disease and its treatment, a problem known as financial toxicity (FT). FT more frequently affects socioeconomically vulnerable individuals and leads to subsequent adverse economic and health outcomes. Whereas multilevel systemic factors at the policy, payer, and provider levels drive FT, there are also accompanying intervenable patient-level factors that exacerbate FT in the setting of clinical care delivery. The primary strategy to intervene on FT at the patient level is financial navigation. Financial navigation uses comprehensive assessment of patients' risk factors for FT, guidance toward support resources, and referrals to assist patient financial needs during cancer care. Social workers or nurse navigators most frequently lead financial navigation. Oncologists and clinical provider teams are multidisciplinary partners who can support optimal FT management in the context of their clinical roles. Oncologists and clinical provider teams can proactively assess patient concerns about the financial hardship and employment effects of disease and treatment. They can respond by streamlining clinical treatment and care delivery planning and incorporating FT concerns into comprehensive goals of care discussions and coordinated symptom and psychosocial care. By understanding how age and life stage, socioeconomic, and cultural factors modify FT trajectory, oncologists and multidisciplinary health care teams can be engaged and informative in patient-centered, tailored FT management. The case presentations in this report provide a practical context to summarize authors' recommendations for patient-level FT management, supported by a review of key supporting evidence and a discussion of challenges to mitigating FT in oncology care. CA Cancer J Clin. 2022;72:437-453.
大约有一半的癌症患者面临与疾病及其治疗相关的个人经济负担,这一问题被称为财务毒性(FT)。FT 更常影响社会经济弱势群体,并导致随后的不良经济和健康后果。虽然政策、支付方和提供者层面的多层次系统性因素导致了 FT,但在临床护理提供方面,也存在伴随的可干预的患者层面因素,使 FT 恶化。在患者层面干预 FT 的主要策略是财务导航。财务导航使用对患者 FT 风险因素的综合评估、对支持资源的指导以及对患者在癌症护理期间财务需求的转介,来帮助患者。社会工作者或护士导航员最常领导财务导航。肿瘤学家和临床提供者团队是多学科合作伙伴,他们可以在其临床角色的背景下支持最佳的 FT 管理。肿瘤学家和临床提供者团队可以主动评估患者对疾病和治疗的经济困难和就业影响的担忧。他们可以通过简化临床治疗和护理计划的制定,以及将 FT 问题纳入全面的护理目标讨论和协调的症状和心理社会护理,来回应患者的担忧。通过了解年龄和生命阶段、社会经济和文化因素如何改变 FT 的轨迹,肿瘤学家和多学科医疗保健团队可以在以患者为中心、量身定制的 FT 管理中发挥作用并提供信息。本报告中的病例介绍提供了一个实际背景,总结了作者对患者层面 FT 管理的建议,这些建议得到了对关键支持证据的审查和对减轻肿瘤学护理中 FT 挑战的讨论的支持。CA 癌症 J Clin. 2022;72:437-453.